Hearing loss affects over 1.5 billion people worldwide and has substantial social, educational, and economic consequences. Although genetic studies have identified numerous hearing-loss-associated genes, the molecular changes accompanying noise-induced hearing loss (NIHL) remain incompletely understood....
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is preclinical mouse research identifying molecular targets; human clinical translation has not yet been demonstrated.
Identifying the protein-level changes that drive noise-induced hearing loss could eventually reveal drug targets for prevention or treatment in humans.
- 01Proteomic profiling of mouse cochlea reveals molecular signatures tied to noise-induced hearing loss.
- 02Builds on prior genetic (genomic) studies by adding a protein-expression layer of analysis.
- 03Study is preclinical (mouse model); human relevance is not yet established.
- 04Could point toward novel therapeutic or preventive targets for noise-induced hearing loss.
- 05Published in Cell Biology International (doi: 10.1002/cbin.70218).
Proteomic analysis of the mouse cochlea can identify molecular signatures associated with noise-induced hearing loss.
studypartially supported- PMID
- 42820356
- DOI
- 10.1002/cbin.70218.
- Journal
- Cell Biology International
- Publication type
- research_article
- Evidence level
- 4
- Population
- Mouse cochlea (animal model)
- Intervention
- Noise exposure with subsequent proteomic analysis of cochlear tissue
Primary outcomes
Identification of proteomic signatures associated with noise-induced hearing loss in the mouse cochlea